When Should You Get Your First Bone Density Screening

Most women should get their first bone density screening at age 65, while men are generally screened at age 70. Younger women with significant risk factors may need screening as early as age 50 or even sooner. The U.S. Preventive Services Task Force (USPSTF) drives these age thresholds for routine care across the United States.

The Age Numbers That Actually Govern Your First Scan

The standard screening age for postmenopausal women in the U.S. is 65, and that figure comes directly from the USPSTF, the federal advisory panel that sets evidence-based clinical benchmarks for preventive care. Men reach the routine screening threshold at age 70, though many insurance plans and physician guidelines vary slightly around that number.

Bone mineral density (BMD), which is the concentration of minerals like calcium and phosphate packed into a given volume of bone tissue, declines progressively after peak bone mass is reached in a person’s late 20s to early 30s. By the time most people reach their mid-60s, that cumulative decline is significant enough that a baseline measurement becomes clinically meaningful.

The American College of Obstetricians and Gynecologists (ACOG), the National Osteoporosis Foundation (NOF), and the American Association of Clinical Endocrinologists (AACE) each publish slightly different guidance documents. All three organizations align on the age 65 threshold for average-risk postmenopausal women, but their recommendations for men and high-risk younger adults differ enough that patients should ask their physician which specific guideline their practice follows.

What a DXA Scan Actually Measures

A DXA scan (dual-energy X-ray absorptiometry, a low-radiation imaging test that measures how dense your bones are) is the gold standard tool used in bone density screening across the United States. The test takes roughly 10 to 30 minutes, involves no injections, and exposes patients to radiation levels of approximately 1 to 10 microsieverts, compared to roughly 100 microsieverts for a standard chest X-ray.

The DXA machine produces two key scores that serve different diagnostic purposes:

A T-score between -1.0 and -2.5 indicates osteopenia, which is low bone mass that has not yet crossed into the clinical definition of osteoporosis but signals elevated future fracture risk. Identifying osteopenia early is one of the most practical benefits of screening before a fracture occurs.

Which Bones Does a DXA Scan Actually Measure?

A standard DXA scan measures bone density at two primary sites: the lumbar spine (typically vertebrae L1 through L4) and the proximal femur, which includes the femoral neck and total hip. These two sites are selected because they predict fracture risk most reliably and respond most visibly to treatment over time.

A peripheral DXA, sometimes called a pDXA, measures density at smaller sites such as the wrist, heel, or finger. Peripheral scans are sometimes offered at pharmacies, health fairs, or mobile screening units. They are significantly less accurate than central DXA and are not appropriate for diagnosing osteoporosis or guiding treatment decisions. A low result on a peripheral scan should always be followed up with a full central DXA at a qualified radiology facility.

Reading Your DXA Report Beyond the T-Score

The Trabecular Bone Score (TBS), which is a texture analysis of the lumbar spine DXA image that estimates bone microarchitecture quality independent of density, is now available on many modern DXA machines. Two patients can have identical T-scores but very different TBS values, with the lower TBS indicating structurally weaker bone despite similar density numbers.

Some facilities also report the Vertebral Fracture Assessment (VFA), a lateral spine image captured during the same DXA session that screens for existing vertebral compression fractures. This matters because up to 30 percent of vertebral fractures are clinically silent, meaning patients fracture vertebrae without ever experiencing acute pain. Identifying existing fractures changes treatment urgency entirely, even when the T-score alone might not trigger medication.

Risk Factors That Pull the Screening Age Earlier

Physicians across the U.S. use the FRAX calculator (Fracture Risk Assessment Tool, a free online algorithm developed by the World Health Organization that estimates a person’s 10-year probability of a major osteoporotic fracture) to quantify individual risk before ordering a scan. Several well-documented clinical conditions and lifestyle patterns justify screening before age 65 in women and before age 70 in men.

Identify the age in years, months, days and minutes given a date of birth with the online age calculator.

Risk factors that commonly trigger early screening:

1. Low body weight, specifically a body mass index below 20 kg/m²
2. A parent who suffered a hip fracture
3. Current tobacco use or a history of heavy smoking
4. Rheumatoid arthritis, a systemic autoimmune disease that accelerates bone loss
5. Long-term corticosteroid use, meaning oral prednisone or equivalent at 5 mg/day or more for 3 or more months
6. Early menopause before age 45, whether natural or surgical
7. Malabsorption conditions such as celiac disease or Crohn’s disease that impair calcium absorption
8. Hyperparathyroidism, a condition where overactive parathyroid glands pull calcium out of bone into the bloodstream
9. Alcohol consumption exceeding 3 or more drinks per day
10. A personal history of a fragility fracture, meaning a broken bone from a fall at standing height or less

Key Finding: The USPSTF recommends screening younger postmenopausal women when their fracture risk equals or exceeds that of a 65-year-old white woman with no additional risk factors, a threshold the FRAX tool can calculate in under two minutes.

Medications That Damage Bone Density and Trigger Earlier Screening

Beyond lifestyle and disease-based risk factors, a growing list of commonly prescribed medications independently accelerates bone loss in ways many patients are never warned about. Physicians managing patients on these drugs should consider baseline DXA scans regardless of age.

Patients on aromatase inhibitors for breast cancer treatment can lose 2 to 3 percent of BMD per year during treatment, producing clinically significant bone loss within just 2 to 3 years of starting therapy. Oncology guidelines from the American Society of Clinical Oncology (ASCO) now specifically recommend baseline DXA at initiation of aromatase inhibitor therapy regardless of patient age.

How Men Fit Into the Screening Picture

Men are notably underscreened for osteoporosis relative to women, despite accounting for roughly one-third of all hip fractures in the United States annually. The National Osteoporosis Foundation recommends that men receive their first DXA scan at age 70, or at age 50 to 69 if significant risk factors are present.

Men lose bone more gradually than women because they never experience the sharp estrogen withdrawal that accompanies female menopause. However, low testosterone, prolonged androgen deprivation therapy used in prostate cancer treatment, and corticosteroid exposure all accelerate bone loss in men at rates that match or exceed what many women experience after menopause. This means the screening age recommendation for men is not a ceiling but a floor.

Why Male Osteoporosis Is Systematically Missed

Men who sustain hip fractures have a one-year mortality rate of approximately 37 percent, meaningfully higher than the rate observed in women after the same injury. Despite this, surveys of primary care physicians consistently show that osteoporosis risk assessment is performed far less frequently in male patients during routine annual visits.

Part of the gap stems from cultural assumptions that osteoporosis is a women’s disease, and part stems from the fact that men do not have a clearly defined hormonal transition equivalent to menopause that prompts physicians to initiate the conversation. Men who want to be proactive should specifically ask their physician about bone health starting at age 60 if any secondary risk factors apply to them.

Racial and Ethnic Differences in Screening Age Considerations

Bone density screening guidelines in the U.S. have historically been calibrated against data derived predominantly from white, non-Hispanic women, creating important nuances that patients of different racial and ethnic backgrounds should understand.

How racial and ethnic background affects screening context:

• Black women have on average 10 to 15 percent higher bone mineral density than white women of comparable age. Despite this advantage, Black women who do sustain osteoporotic fractures face worse recovery outcomes and are less likely to receive a bone density test or osteoporosis treatment afterward.
• Hispanic women have intermediate BMD levels compared to white and Black women and carry a fracture risk that is frequently underestimated by FRAX because the tool uses race as a correction factor that may not fully capture individual variation.
• Asian American women, particularly those of East Asian descent, have lower average BMD than white women and a higher prevalence of osteoporosis, yet are screened at lower rates and sometimes undertreated because their smaller bone size produces lower absolute fracture rates even at equivalent T-scores.
• Native American and Alaska Native populations have limited representation in osteoporosis research, creating genuine data gaps that make individualized risk assessment more challenging.

The FRAX calculator includes a race field, but many clinicians and researchers have raised valid concerns that the racial correction factors embedded in the tool reflect historical data gaps rather than true biological differences. Patients from any background should discuss their specific heritage and family history with their physician rather than relying solely on population-level averages.

Insurance Coverage and Out-of-Pocket Costs

Medicare Part B covers DXA bone density scans once every 24 months for beneficiaries who meet eligibility criteria, including all women aged 65 and older and men at elevated risk. Most private insurance plans follow similar coverage logic, particularly for patients whose physicians document medical necessity.

Patients who are uninsured can sometimes access lower-cost scans through federally qualified health centers, academic medical centers running research protocols, or local health department screening events. The American Bone Health organization maintains a state-by-state resource list for reduced-cost screening options.

How to Get Insurance to Cover an Early Scan

Patients under the standard screening ages who believe they qualify for early screening based on risk factors frequently encounter coverage denials on first submission. Several practical steps improve the likelihood of approval:

1. Ask the ordering physician to document specific risk factors in the referral note using ICD-10 diagnostic codes rather than general language. Code M81.0 (age-related osteoporosis without current pathological fracture) and Z82.61 (family history of arthritis) are examples that support medical necessity.
2. Request that the physician submit a prior authorization request before the scan is performed, including FRAX score printouts when available.
3. If the first claim is denied, file a formal appeal citing the USPSTF recommendation language, which insurers are legally required to consider under the Affordable Care Act for preventive services.
4. Check whether the employer health plan is classified as a grandfathered plan under the ACA, because grandfathered plans are not required to cover USPSTF-recommended preventive services without cost sharing.

Secondary Causes of Bone Loss Worth Ruling Out Before Age 65

Secondary osteoporosis, which is BMD reduction caused by an identifiable underlying medical condition rather than aging alone, affects a meaningful proportion of adults diagnosed with osteoporosis before the standard screening ages. Identifying a secondary cause can sometimes halt or reverse bone loss entirely by treating the root condition.

Conditions associated with secondary osteoporosis include:

• Vitamin D deficiency, the most common correctable contributor in the U.S. population
• Hyperthyroidism, where excess thyroid hormone accelerates bone turnover
• Type 1 diabetes, which impairs bone quality independent of density measurements
• Chronic kidney disease, which disrupts the activation of vitamin D and calcium regulation
• Multiple myeloma, a plasma cell cancer that destroys bone from the inside
• Anorexia nervosa, which causes hormonal disruption severe enough to match postmenopausal bone loss rates in young women

Lab Tests That Should Accompany a First Bone Density Diagnosis

When a first DXA scan returns an abnormal result, a structured laboratory workup to rule out secondary causes should precede pharmacologic treatment. Treating low bone density without identifying a reversible underlying cause can result in inadequate medication response and missed diagnoses of serious conditions.

This panel costs roughly $200 to $600 when billed separately without insurance coverage, but most components are included in standard annual bloodwork panels that many patients already receive, meaning the incremental cost of adding the bone-specific markers is often modest.

Bone Density Screening During and After Specific Life Events

Menopause Timing and the Bone Loss Acceleration Window

The first 5 to 7 years following menopause represent the period of most rapid bone loss in a woman’s lifetime, with some women losing 3 to 5 percent of spinal bone density per year during this window. This is driven by the sharp decline in estrogen, which normally suppresses osteoclast activity, the cellular process that breaks down bone tissue.

Women who enter menopause before age 45, whether through natural early menopause or surgical removal of the ovaries, experience this accelerated loss phase earlier and for a longer total duration before reaching the standard screening age of 65. A woman who undergoes bilateral oophorectomy at age 40 may spend 25 years in an estrogen-deficient state before her first routine scan, during which she can lose bone at rates that would qualify for treatment had anyone checked. Physicians managing early menopause should consider ordering a baseline DXA scan within 1 to 2 years of estrogen loss onset.

Screening After Organ Transplantation

Solid organ transplant recipients, including kidney, liver, heart, and lung transplant patients, face an extraordinarily high rate of post-transplant bone loss driven by high-dose immunosuppressive regimens that include corticosteroids. Studies show that transplant patients can lose 10 to 15 percent of bone density in the first year after transplantation.

Major transplant societies, including the American Society of Transplantation, recommend baseline DXA at the time of transplant listing and repeat scanning at 6 and 12 months post-transplant regardless of patient age or sex. This is one of the few clinical scenarios where bone density screening is recommended in young adults without any other identifiable risk factor beyond the transplant itself.

Pregnancy-Associated Osteoporosis

Pregnancy-associated osteoporosis (PAO) causes severe vertebral fractures in previously healthy women, typically during the third trimester or early postpartum period. PAO affects an estimated 1 in 100,000 pregnancies in the United States and is frequently misdiagnosed as musculoskeletal back pain until imaging reveals vertebral collapse.

Women who experience severe back pain during or immediately after pregnancy, particularly if accompanied by height loss, should request vertebral fracture assessment rather than waiting for routine screening ages to apply. PAO is distinct from the minor, transient bone density reduction that affects all pregnant women and typically resolves after weaning.

What Happens After Your First Scan

A normal result does not require re-scanning for up to 15 years in low-risk postmenopausal women, according to research published in the New England Journal of Medicine. Patients with osteopenia typically receive follow-up scans every 1 to 5 years depending on severity, while a diagnosis of osteoporosis triggers both pharmacologic evaluation and more frequent monitoring.

Medications the FDA has approved for osteoporosis treatment or prevention in the U.S.:

• Bisphosphonates such as alendronate (Fosamax) and risedronate (Actonel), which slow bone breakdown and are typically first-line agents
• Denosumab (Prolia), a biologic injection given every 6 months that blocks the protein signal driving bone resorption
• Teriparatide (Forteo) and abaloparatide (Tymlos), synthetic parathyroid hormone analogs that actively build new bone tissue
• Romosozumab (Evenity), a newer injectable that simultaneously builds bone and slows its breakdown, approved for postmenopausal women at high fracture risk
• Raloxifene (Evista), a selective estrogen receptor modulator that reduces vertebral fracture risk while also lowering breast cancer risk in high-risk women

The specific drug selected depends on fracture risk score, T-score severity, comorbidities, and patient preference. No medication replaces adequate calcium and vitamin D intake, which underpin all pharmacologic strategies.

The Drug Holiday Question After Bisphosphonate Treatment

Patients on oral bisphosphonates should be reassessed after 3 to 5 years of treatment, per recommendations from the American Society for Bone and Mineral Research (ASBMR). Those who have responded well and whose T-score has improved to above -2.5 may safely pause medication for 1 to 3 years while continuing calcium, vitamin D, and lifestyle measures, because bisphosphonates accumulate in bone and continue working for months to years after the last dose.

Patients at very high fracture risk typically continue treatment or transition to a different drug class. This means the first bone density scan is not just a diagnostic moment but the starting point of a long-term monitoring and treatment arc that plays out over decades.

Lifestyle Choices That Meaningfully Shift the Screening Timeline

Bone density at the time of a first screening is not purely a function of age. Decades of lifestyle accumulate inside the skeleton, and two people of identical age can present with dramatically different BMD readings based on behaviors that began in adolescence.

Factors that build bone mass and may delay clinical concern:

• Weight-bearing exercise, particularly resistance training and impact activities like running or jumping
• Consistent calcium intake of 1,000 mg per day for adults under 50 and 1,200 mg per day for women over 50 and men over 70
• Vitamin D3 supplementation to maintain serum 25-hydroxyvitamin D levels above 30 ng/mL
• Avoiding prolonged periods of immobility or bed rest

Factors that accelerate bone loss and warrant earlier first screening:

• Smoking even at moderate levels reduces BMD measurably and independently
• Excessive alcohol consumption disrupts bone-forming osteoblast cells
• Very low calorie diets sustained over months suppress bone-building hormones
• Sedentary behavior over years reduces the mechanical loading that signals bone to maintain density

Calcium Supplementation: The Nuance That Matters

Food-first calcium is preferred over supplementation when dietary intake is adequate, per the National Academy of Medicine. Adults who consume 3 or more servings of dairy or calcium-fortified foods daily typically meet their calcium needs without supplementation.

When supplementation is necessary, splitting doses to no more than 500 to 600 mg per sitting maximizes absorption because the intestinal transport mechanism saturates at higher single doses. Several large studies raised concerns that calcium supplementation without concurrent vitamin D may be associated with increased cardiovascular risk in some populations, though this finding remains actively debated in the literature.

Exercise Type Matters More Than Total Activity Volume

Aerobic activities performed in water or on a bicycle provide minimal bone-building stimulus because they are not weight-bearing and do not generate the mechanical impact that signals bone to maintain or increase density. The most bone-protective exercise modalities are:

1. Progressive resistance training with free weights, machines, or resistance bands targeting major muscle groups at least 2 to 3 days per week
2. Impact activities such as jogging, hiking, tennis, basketball, or jumping rope that generate ground reaction forces exceeding body weight
3. Tai chi, which produces modest BMD benefits but meaningfully reduces fall risk and fall-related fractures through improved balance and proprioception
4. Yoga and Pilates, which build core strength and postural muscle tone but should be modified to avoid spinal flexion exercises in patients already diagnosed with osteoporosis, as forward bending under load can trigger vertebral compression fractures

Pediatric and Young Adult Screening: The Narrow Exceptions

The International Society for Clinical Densitometry (ISCD) has established guidelines for when DXA is appropriate before age 50 in females and before age 70 in males. These narrow exceptions apply to children and adolescents receiving long-term glucocorticoid therapy, young adults with conditions causing chronic malabsorption, patients of any age who have sustained a fragility fracture, and individuals with a disease known to cause secondary osteoporosis.

Z-scores rather than T-scores are used for anyone under age 50, because comparing younger patients to a 30-year-old peak-bone-mass reference (as T-scores do) would artificially inflate abnormality rates in groups where lower bone mass is expected and age-appropriate.

Athletes and Bone Density: The Female Athlete Triad

The Female Athlete Triad consists of three interconnected conditions: low energy availability (insufficient caloric intake relative to energy expenditure), menstrual dysfunction or amenorrhea (loss of regular menstrual cycles), and low bone mineral density. Female athletes who have experienced 3 or more consecutive missed menstrual cycles due to energy restriction should receive a DXA scan regardless of age, because the hormonal disruption driving amenorrhea is biochemically nearly identical to the estrogen withdrawal of menopause.

The Relative Energy Deficiency in Sport (RED-S) framework extends the original Triad concept to male athletes and a broader range of physiological systems. Male athletes in endurance sports and weight-class sports who chronically restrict calories face analogous risks through testosterone suppression, though they present at lower rates and are diagnosed even less frequently than their female counterparts.

Connecting Screening Age to Fracture Prevention Outcomes

Hip fractures in Americans aged 65 and older carry a 20 to 30 percent mortality rate within one year, making them far more lethal than most people appreciate. Vertebral compression fractures affect an estimated 1.5 million Americans annually and are frequently the first clinical sign that significant bone loss has already occurred, often without any fall or acute pain episode.

Catching low bone density before that first fracture is precisely what the screening age thresholds are designed to achieve. A patient who learns at age 65 that her T-score is -2.2 has time to begin treatment, modify lifestyle, and reduce her fracture probability before she enters her highest-risk years in her 70s and 80s.

Fall Prevention as the Missing Layer of Fracture Risk

Falls are the proximate cause of the vast majority of hip and wrist fractures, and fall risk is driven by factors entirely separate from BMD, including muscle weakness, balance impairment, vision problems, polypharmacy, and home environmental hazards.

Medications that meaningfully increase fall risk and therefore fracture risk:

• Benzodiazepines such as alprazolam and lorazepam that impair balance and coordination
• Sleep aids including zolpidem (Ambien), which causes next-morning sedation
• Blood pressure medications that cause orthostatic hypotension, a sudden drop in blood pressure upon standing
• Antidepressants and antipsychotics that affect vestibular function
• Opioid analgesics that impair motor coordination

Physicians managing older adults should conduct a formal fall risk assessment at the same visit where bone density results are discussed. The Timed Up and Go (TUG) test, which measures how long it takes a patient to rise from a chair, walk 3 meters, turn, and return to seated, is a validated no-equipment tool that takes under 2 minutes and predicts fall risk with meaningful accuracy. A TUG time exceeding 12 seconds in older adults is associated with elevated fall risk.

The Fracture Liaison Service Model

Fracture Liaison Services (FLS) are coordinated care programs that automatically identify patients who present to emergency departments or orthopedic clinics with fragility fractures and connect them to bone density evaluation and treatment. The FLS model has demonstrated reductions in secondary fracture rates of 40 to 50 percent in systems that have implemented it fully.

The majority of patients who sustain a fragility fracture in the United States are discharged without any bone density evaluation or osteoporosis treatment initiation. Patients who fracture a wrist, hip, shoulder, or vertebra should specifically ask their treating physician or orthopedic surgeon for a referral to bone health evaluation before leaving the care setting.

How to Prepare for Your First Bone Density Scan

Taking a few straightforward steps before a first DXA appointment ensures the numbers returned reflect true bone status rather than measurement artifacts.

What to do before your appointment:

1. Avoid calcium supplements for 24 hours before the scan. Recent calcium ingestion can create artifacts in some scan regions. Checking with the scheduling facility beforehand is worthwhile.
2. Wear comfortable, metal-free clothing. Underwire bras, metal belt buckles, snaps, and zippers in the scan region must be removed or avoided because metal creates signal interference that distorts density readings.
3. Bring a list of all current medications, including supplements, so the technologist and interpreting physician can note drugs that affect bone metabolism.
4. Inform the facility if you have had a barium study, nuclear medicine scan, or contrast-enhanced CT within the previous 7 days. Residual contrast agents in the body can interfere with DXA signal.
5. Tell the technologist your weight accurately. Most DXA machines have a table weight limit of 300 to 450 pounds depending on model, and exceeding it requires referral to a bariatric-capable facility.
6. Ask whether the facility will perform your follow-up scans on the same machine. BMD comparisons between scans are most accurate when performed on the same DXA unit, because calibration differences between machines can produce apparent changes in BMD that reflect equipment variation rather than true biological change.

Interpreting Your Results in Plain Language

A practical translation of what common T-score ranges mean for daily life and clinical decision-making:

A T-score alone does not tell the complete story. A woman with a T-score of -2.3 and no other risk factors has a meaningfully different absolute fracture probability than a woman with the same T-score who smokes, has a mother who fractured her hip, and has been on prednisone for two years.

The general treatment threshold used by most U.S. physicians is a FRAX-calculated 10-year hip fracture probability of 3 percent or greater, or a 10-year major osteoporotic fracture probability of 20 percent or greater, as established by the National Osteoporosis Foundation. Patients whose scores fall below these thresholds despite a low T-score may reasonably defer medication while intensifying lifestyle strategies.

FAQ’s

What age should a woman get her first bone density test?

Most women should receive their first bone density test at age 65, per the U.S. Preventive Services Task Force. Women under 65 who are postmenopausal and have risk factors such as low body weight, early menopause, or a parent with a hip fracture may qualify for earlier screening based on physician assessment.

At what age do men get bone density screening?

Men are typically recommended for bone density screening at age 70, or at age 50 to 69 if risk factors such as low testosterone, corticosteroid use, or a history of fracture are present. Men are significantly underscreened despite representing roughly one-third of hip fracture cases in the United States.

Does Medicare cover bone density screening?

Medicare Part B covers DXA bone density scans once every 24 months at no additional cost beyond the standard Part B deductible for eligible beneficiaries, including all women 65 and older and men who meet medical necessity criteria. Beneficiaries should confirm their specific facility is Medicare-participating before scheduling.

What is a normal bone density T-score?

A T-score of -1.0 or higher is considered normal. Scores between -1.0 and -2.5 indicate osteopenia, which is low bone mass but not yet osteoporosis. A T-score of -2.5 or lower meets the clinical definition of osteoporosis and typically triggers treatment evaluation.

Can a 40-year-old get a bone density test?

A 40-year-old can receive a bone density test if a physician identifies a clinical reason, such as a fragility fracture, chronic corticosteroid use, or a condition causing secondary bone loss like celiac disease or hyperparathyroidism. Routine screening for low-risk adults in their 40s is not currently recommended by major U.S. guidelines.

How often should you repeat a bone density test?

Women with normal baseline results and low risk factors may wait up to 15 years before repeating a DXA scan, according to research from the New England Journal of Medicine. Women with osteopenia are typically rescanned every 1 to 5 years, and those on osteoporosis medication are often monitored every 1 to 2 years to assess treatment response.

What is the difference between osteoporosis and osteopenia?

Osteopenia refers to bone mineral density that is below average for a healthy young adult but not low enough to meet the clinical threshold for osteoporosis, specifically a T-score between -1.0 and -2.5. Osteoporosis is diagnosed at a T-score of -2.5 or lower and carries a substantially higher risk of fracture from minor falls or everyday stress.

Is a DEXA scan the same as a bone density test?

Yes. A DEXA scan (also written DXA, short for dual-energy X-ray absorptiometry) is the standard test used for bone density measurement in the United States and is the same procedure most people mean when they say bone density test. It uses two low-dose X-ray beams to measure mineral content in bones, most commonly the spine and hip.

What risk factors lower the bone density screening age?

Risk factors that commonly lead physicians to recommend screening before age 65 include early menopause before age 45, low body weight, long-term corticosteroid use, tobacco use, heavy alcohol consumption, rheumatoid arthritis, a parental history of hip fracture, and malabsorption conditions like celiac disease. The FRAX calculator can quantify combined risk to support that decision.

How much does a bone density test cost without insurance?

Self-pay costs for a DXA bone density scan in the United States typically range from $100 to $300 at outpatient imaging centers, though hospital-based radiology departments may charge $250 to $500 or more. Federally qualified health centers and community health programs sometimes offer reduced-cost or sliding-scale options for uninsured patients.

Can you get a bone density test during pregnancy?

DXA scans are generally avoided during pregnancy because the test involves ionizing radiation, even at the low levels used. Physicians typically defer non-urgent bone density screening until after delivery and the conclusion of breastfeeding, when hormonal status has stabilized and radiation exposure carries no risk to a fetus.

What can I do to improve bone density before my first screening?

The most evidence-supported strategies include consistent weight-bearing and resistance exercise, adequate daily calcium intake of 1,000 to 1,200 mg, maintaining vitamin D levels above 30 ng/mL, avoiding smoking, and limiting alcohol to fewer than 2 drinks per day. These changes have measurable effects on BMD over months to years and can positively influence T-score results at the time of a first scan.

Does height loss mean I should get a bone density test sooner?

Losing more than 1.5 inches of height over time is a recognized clinical signal of vertebral compression fractures, which are often caused by osteoporosis. Physicians frequently use unexplained height loss as a prompt to order a DXA scan regardless of the patient’s age, because vertebral fractures can occur silently and indicate bone density has already fallen to a level requiring intervention.

What is the FRAX calculator and should I use it?

The FRAX calculator is a free, publicly accessible online tool developed by the World Health Organization that estimates a person’s 10-year probability of hip fracture and major osteoporotic fracture based on age, sex, weight, height, and clinical risk factors. Adults over 40 can use it to generate a preliminary risk estimate, though results should always be interpreted by a physician who can factor in DXA results and full medical history.

What is the difference between a central DXA and a peripheral bone density test?

A central DXA measures bone density at the spine and hip and is the only test appropriate for diagnosing osteoporosis and guiding treatment decisions. A peripheral DXA measures density at smaller sites like the wrist or heel and is sometimes offered at pharmacies or health fairs but cannot be used alone to diagnose osteoporosis or determine whether medication is warranted.

Can osteoporosis be reversed with treatment?

Osteoporosis cannot be fully reversed in the sense of returning bone to its peak-mass state, but treatment can meaningfully increase bone mineral density and reduce fracture risk. Anabolic agents like teriparatide and romosozumab have been shown to increase spinal BMD by 9 to 13 percent over 18 to 24 months in clinical trials, translating to clinically significant fracture risk reduction.

What foods are highest in calcium for bone health?

The highest dietary sources of calcium include plain yogurt at approximately 450 mg per cup, sardines with bones at approximately 350 mg per 3-ounce serving, cow’s milk at approximately 300 mg per cup, fortified plant-based milks at approximately 300 to 450 mg per cup, and firm tofu made with calcium sulfate at approximately 250 to 350 mg per half-cup. Leafy greens like kale and bok choy provide roughly 100 to 150 mg per cooked cup, though spinach contains oxalates that significantly reduce calcium absorption.

Should I get a bone density test if I take prednisone?

Patients taking oral prednisone or equivalent corticosteroids at 5 mg per day or more for 3 or more months should receive a baseline DXA scan regardless of age, per guidelines from the American College of Rheumatology. Glucocorticoid-induced osteoporosis (GIOP) is the most common form of secondary osteoporosis and is significantly underdiagnosed because physicians managing the underlying inflammatory condition do not always coordinate with bone health specialists.

Is bone density screening recommended after breast cancer treatment?

Women receiving aromatase inhibitor therapy for hormone receptor-positive breast cancer should have a baseline DXA scan at initiation of treatment, per guidelines from the American Society of Clinical Oncology. Aromatase inhibitors suppress estrogen production dramatically and can cause 2 to 3 percent annual bone loss, making monitoring and often preventive treatment with bisphosphonates necessary throughout the course of cancer therapy.

What happens if I miss my scheduled bone density rescreening?

Missing a scheduled rescreening does not create immediate harm, as bone changes occur gradually, but patients on osteoporosis medication who delay rescreening lose the opportunity to assess treatment response and adjust therapy. Patients with untreated osteopenia who miss a scheduled rescan may unknowingly progress to osteoporosis during the gap, and rescanning should be rescheduled as soon as possible with the interval clock resetting from the date of the next completed scan.